Manuela G Neuman

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. ncbi Hyaluronic acid signals for repair in ethanol-induced apoptosis in skin cells in vitro
    Manuela G Neuman
    Department of Clinical Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada M56 1L7
    Clin Biochem 43:822-6. 2010
  2. ncbi In vitro anti-inflammatory effects of hyaluronic acid in ethanol-induced damage in skin cells
    Manuela G Neuman
    Department of Clinical Pharmacology, University of Toronto, Toronto, Ontario, Canada
    J Pharm Pharm Sci 14:425-37. 2011
  3. ncbi The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review
    Jurgen Rehm
    Public Health and Regulatory Policies, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    BMC Public Health 9:450. 2009
  4. ncbi Immune dysfunction in inflammatory bowel disease
    Manuela G Neuman
    Department of Pharmacology and Institute of Drug Research, University of Toronto, Toronto, Ontario, Canada
    Transl Res 149:173-86. 2007
  5. ncbi Apoptosis in ibuprofen-induced Stevens-Johnson syndrome
    Manuela Neuman
    In Vitro Drug Safety and Biotechnology Laboratory, University of Toronto, Toronto, Ontario, Canada
    Transl Res 149:254-9. 2007
  6. ncbi Senecio latifolius induces in vitro hepatocytotoxicity in a human cell line
    Manuela G Neuman
    In Vitro Drug Safety and Biotechnology, Department of Pharmacology, Institute of Drug Research, University of Toronto, South Tower of the MaRS Discovery Centre, 101 College Street, Toronto, ON M5G 1L5, Canada
    Can J Physiol Pharmacol 85:1063-75. 2007
  7. ncbi Predicting possible zonisamide hypersensitivity syndrome
    Manuela G Neuman
    In Vitro Drug Safety and Biotechnology Laboratory, MaRS Discovery Centre, University of Toronto, Toronto, ON, Canada
    Exp Dermatol 17:1045-51. 2008
  8. ncbi Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides
    Manuela G Neuman
    In Vitro Drug Safety and Biotechnology Laboratory, University of Toronto, Toronto, Ontario, Canada
    Transl Res 149:243-53. 2007
  9. ncbi Cytokine--chemokine and apoptotic signatures in patients with hepatitis C
    Manuela G Neuman
    In Vitro Drug Safety and Biotechnology, MaRS Discovery Center, 101 College Street, Lab 351, Toronto, Ontario, M5G 1L7 Canada
    Transl Res 149:126-36. 2007
  10. ncbi Role of cytokines in the assessment of the severity of chronic hepatitis C and the prediction of response to therapy
    Manuela G Neuman
    Division of Clinical Pharmacology E-240, Sunnybrook and Women's College Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada
    Rom J Gastroenterol 11:97-103. 2002

Detail Information

Publications31

  1. ncbi Hyaluronic acid signals for repair in ethanol-induced apoptosis in skin cells in vitro
    Manuela G Neuman
    Department of Clinical Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada M56 1L7
    Clin Biochem 43:822-6. 2010
    ..Ethanol is commonly used in cosmetic and pharmaceutical preparations...
  2. ncbi In vitro anti-inflammatory effects of hyaluronic acid in ethanol-induced damage in skin cells
    Manuela G Neuman
    Department of Clinical Pharmacology, University of Toronto, Toronto, Ontario, Canada
    J Pharm Pharm Sci 14:425-37. 2011
    ..Ethyl alcohol (ethanol) is commonly applied in cosmetic and pharmaceutical preparations, as well as disinfectant for chronic wounds...
  3. ncbi The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review
    Jurgen Rehm
    Public Health and Regulatory Policies, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    BMC Public Health 9:450. 2009
    ..8%) and 2.2% of global burden of disease (men 2.7%; women 1.7%). The present work portrays accumulated evidence on the association between alcohol consumption and TB with the aim to clarify the nature of the relationship...
  4. ncbi Immune dysfunction in inflammatory bowel disease
    Manuela G Neuman
    Department of Pharmacology and Institute of Drug Research, University of Toronto, Toronto, Ontario, Canada
    Transl Res 149:173-86. 2007
    ..Furthermore, this study highlights the potential use of cytokines, anti-cytokine antibodies, and cytokine-related biologic therapies as novel targets for the treatment of IBD...
  5. ncbi Apoptosis in ibuprofen-induced Stevens-Johnson syndrome
    Manuela Neuman
    In Vitro Drug Safety and Biotechnology Laboratory, University of Toronto, Toronto, Ontario, Canada
    Transl Res 149:254-9. 2007
    ..The same is the case with the apoptotic markers Fas, caspase activity, and M30. T-cell cytokines control the pathogenesis of SJS/TEN contributing to apoptotic processes in the liver and in the skin...
  6. ncbi Senecio latifolius induces in vitro hepatocytotoxicity in a human cell line
    Manuela G Neuman
    In Vitro Drug Safety and Biotechnology, Department of Pharmacology, Institute of Drug Research, University of Toronto, South Tower of the MaRS Discovery Centre, 101 College Street, Toronto, ON M5G 1L5, Canada
    Can J Physiol Pharmacol 85:1063-75. 2007
    ..Cytotoxicity is reduced by supplementation with NAC, which thus prevents GSH depletion. Caspase activation is involved in Senecio-induced apoptosis...
  7. ncbi Predicting possible zonisamide hypersensitivity syndrome
    Manuela G Neuman
    In Vitro Drug Safety and Biotechnology Laboratory, MaRS Discovery Centre, University of Toronto, Toronto, ON, Canada
    Exp Dermatol 17:1045-51. 2008
    ..The second aim was to determine age-related differences in ZNS-induced HSR. LTA was previously validated in patients who received sulphamethoxazole (SMX) or AC...
  8. ncbi Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides
    Manuela G Neuman
    In Vitro Drug Safety and Biotechnology Laboratory, University of Toronto, Toronto, Ontario, Canada
    Transl Res 149:243-53. 2007
    ....
  9. ncbi Cytokine--chemokine and apoptotic signatures in patients with hepatitis C
    Manuela G Neuman
    In Vitro Drug Safety and Biotechnology, MaRS Discovery Center, 101 College Street, Lab 351, Toronto, Ontario, M5G 1L7 Canada
    Transl Res 149:126-36. 2007
    ..In conclusion, cytokines, chemokines and apoptosis levels reflect the progression of inflammation and fibrosis in hepatitis C infected patients, but their signatures differ...
  10. ncbi Role of cytokines in the assessment of the severity of chronic hepatitis C and the prediction of response to therapy
    Manuela G Neuman
    Division of Clinical Pharmacology E-240, Sunnybrook and Women's College Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada
    Rom J Gastroenterol 11:97-103. 2002
    ..In addition, it is able to reduce fibrosis as judged both by TGF-beta levels and fibrosis scores as compared to standard therapy...
  11. ncbi Inflammation and repair in viral hepatitis C
    Manuela G Neuman
    In Vitro Drug Safety and Biotechnology, Department of Pharmacology, Biophysics and Global Health, Institute of Drug Research, University of Toronto, Toronto, ON, Canada
    Dig Dis Sci 53:1468-87. 2008
    ..This review will also aim to describe the importance of IFN-alpha-based therapies in HCV infection, ways of monitoring them, and associated complications...
  12. ncbi Ethanol signals for apoptosis in cultured skin cells
    Manuela G Neuman
    Departments of Clinical Pharmacology, Dermatology, Medicine, and Laboratory Medicine, University of Toronto, M5S 1A1, Toronto, Ontario, Canada
    Alcohol 26:179-90. 2002
    ..Therefore, even at low concentrations, ethanol may induce apoptosis in skin cells by enhancing the effects of TNF-alpha...
  13. ncbi Safety of celecoxib in individuals allergic to sulfonamide: a pilot study
    Lori E Shapiro
    Division of Clinical Pharmacology, Drug Safety Research Group, University of Toronto, Toronto, Ontario, Canada
    Drug Saf 26:187-95. 2003
    ..To evaluate cross reactivity between sulfonamide antimicrobials and celecoxib in patients with histories of allergies to sulfonamide antimicrobials...
  14. ncbi Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency virus-infected individuals
    Manuela G Neuman
    Department of Pharmacology, University of Toronto, Canada
    Ther Drug Monit 24:728-36. 2002
    ..Larger patient populations, as well as in vitro studies are needed to further address the reasons for elevated results in immunocompromised patients and to validate the usefulness of the test...
  15. ncbi Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy
    Manuela G Neuman
    Division of Clinical Pharmacology, E 240, Sunnybrook and Women s College Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada
    Cytokine 17:108-17. 2002
    ....
  16. ncbi Colorectal polyposis and immune-based therapies
    Pearl Jacobson-Brown
    In Vitro Toxicology Laboratory, Kunin-Lunenfeld Applied Research Unit, Baycrest Centre for Geriatric Care, Toronto, Ontario
    Can J Gastroenterol 18:239-49. 2004
    ..The present review aims to discuss the immunological mechanisms underlying colon tumour progression and the molecular and immune-based therapies that are leading to new methods of prognosis and treatment...
  17. ncbi An electron microscopic and morphometric study of ursodeoxycholic effect in primary biliary cirrhosis
    Manuela G Neuman
    Division of Clinical Pharmacology, Sunnybrook and Women s Health Sciences Centre, Toronto, Ontario, Canada
    Liver 22:235-44. 2002
    ..The study attempted to quantify perisinusoidal collagenization and the number of apoptotic bodies in PBC liver biopsies from patients in a randomized control trial treated with UDCA compared to those who received placebo...
  18. ncbi Mechanism of Impila (Callilepis laureola)-induced cytotoxicity in Hep G2 cells
    Alpa Popat
    Division of Clinical Pharmacology, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada
    Clin Biochem 35:57-64. 2002
    ..CONCLUSION: Our results suggest the mechanism of Impila-induced cytotoxicity in Hep G2 cells in vitro involves depletion of cellular GSH. Preventing GSH depletion by supplementing cells with NAC reduces cytotoxicity...
  19. ncbi Ibuprofen-induced hypersensitivity syndrome
    Radu M Nanau
    Department of In Vitro Drug Safety and Biotechnology and the Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    Transl Res 155:275-93. 2010
    ..Our review presents an ibuprofen-induced clinical manifestation of hypersensitivity syndrome and the necessity of wisely monitoring the patients clinically and by laboratory investigations when prescribing this drug...
  20. ncbi HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury
    Manuela G Neuman
    Departments of Clinical Pharmacology and Toxicology, and Global Health, University of Toronto, ON, Canada M5G 1X8
    Int J Hepatol 2012:760706. 2012
    ....
  21. ncbi Alcoholic liver injury and apoptosis--synopsis of the symposium held at ESBRA 2001: 8th Congress of the European Society for Biomedical Research on Alcoholism, Paris, September 16, 2001
    Manuela G Neuman
    Division of Clinical Pharmacology, Sunnybrook and Women's College Health Sciences Centre, Room E235, 2075 Bayview Ave, Ontario, M4N 3M5, Toronto, Canada
    Alcohol 28:117-28. 2002
  22. ncbi Tumor necrosis factor alpha as a noninvasive marker of liver inflammation in patients with viral hepatitis C
    Asma Ibrahim
    Division of Clinical Pharmacology, E-235, Sunnybrook and Women's College Health Sciences Centre, 2075 Bayview Ave, Toronto, Ontario M4N 3M5, Canada
    Am Clin Lab 21:12-5. 2002
  23. ncbi Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs
    Manuela G Neuman
    In Vitro Drug Safety and Biotechnology, University of Toronto, Toronto, Ontario, Canada Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada
    Transl Res 159:397-406. 2012
    ..There is cross-reactivity between AEDs. Additionally, T-cell cytokines and chemokines control the pathogenesis of SJS/TEN and DILI, contributing to apoptotic processes in the liver and in the skin...
  24. ncbi Signaling for inflammation and repair in inflammatory bowel disease
    Manuela G Neuman
    In Vitro Toxicology Laboratory, Center for Addiction and Mental Health, 33 Russell Street, Room 2035, Toronto, ON M5S 2S1, Canada
    Rom J Gastroenterol 13:309-16. 2004
    ..Knowledge of objective evidence of inflammatory activity may allow targeted treatment at an earlier stage to avoid the relapse, as well as assessment of new therapeutic strategies for maintenance of remission...
  25. ncbi Synergetic signaling for apoptosis in vitro by ethanol and acetaminophen
    Manuela G Neuman
    In Vitro Toxicology Laboratory, Division of Clinical Pharmacology, Sunnybrook and Women's College Health Sciences Centre, Room E235, 2075 Bayview Ave, Toronto, Ontario, Canada M4N 3M5
    Alcohol 27:89-98. 2002
    ..The modulation of mitochondrial damage in vitro may have implications for the development of new therapeutic strategies to prevent apoptosis...
  26. ncbi Cytokines--central factors in alcoholic liver disease
    Manuela G Neuman
    In Vitro Toxicology Laboratory in the Kunin-Lunenfeld Applied Research Unit, Baycrest Centre for Geriatric Care, Toronto, Canada
    Alcohol Res Health 27:307-16. 2003
    ..Because of their diverse functions, cytokines might make attractive targets in the prevention or treatment of alcoholic liver disease, and researchers already have obtained encouraging results when testing such approaches...
  27. ncbi Alcohol Consumption, Progression of Disease and Other Comorbidities, and Responses to Antiretroviral Medication in People Living with HIV
    Manuela G Neuman
    Departments of Pharmacology and Toxicology and Global Health, University of Toronto, Toronto, ON, Canada M5S 1A1
    AIDS Res Treat 2012:751827. 2012
    ..Our intention was to fully characterize the quality of evidence supporting recommendations, which are reflecting benefit versus risk, and assessing strength or certainty...
  28. ncbi Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis
    Manuela G Neuman
    Division of Clinical Pharmacology, Sunnybrook and Women s College Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada
    J Viral Hepat 9:134-40. 2002
    ..In conclusion, serum TNF-alpha reflects the progression of inflammation as seen in liver biopsies and TGF-beta reflects the degree of fibrosis in HCV patients...
  29. ncbi Colon polyps and cytokines: emerging immunological mechanisms
    Pearl Jacobson-Brown
    In Vitro Toxicology Laboratory, Division of Clinical Pharmacology, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada
    Rom J Gastroenterol 12:207-14. 2003
    ..This review aims to increase knowledge of the immunological mechanisms underlying colon tumour progression in the hopes that a greater understanding of the molecular pathways will lead to improved methods of prognosis and treatment...
  30. ncbi Antiepileptic drug-induced hypersensitivity syndrome reactions
    Norberto Krivoy
    Department of Medicine B and Clinical Pharmacology Unit, Rambam Medical Center and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
    Curr Drug Saf 1:289-99. 2006
    ....
  31. ncbi Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses
    Manuela G Neuman
    Pan American Health Organization, Washington, DC, USA
    Subst Use Misuse 41:1395-463. 2006
    ....